PEDIATRICS Vol. 97 No. 2 February 1996, pp. 232-235
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Serres, G.
Right arrow Articles by Corriveau, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Serres, G.
Right arrow Articles by Corriveau, A.

Effectiveness of Vaccination at 6 to 11 Months of Age During an Outbreak of Measles

Gaston De Serres MD1, Nicole Boulianne RN, MSc1, Sam Ratnam PhD, MPH2, and André Corriveau MD, FRCP(C)3

1 The Centre de Santé Publique de Québec, Ste-Foy, Québec
2 Newfoundland Public Health Laboratory, St. John's, Newfoundland
3 Inuulitsivik Health Center, Povungnituk, Québec, Canada.

Hypothesis. Monovalent measles vaccine can be administered to children 6 to 11 months of age during an outbreak. Efficacy and effectiveness of this control measure still have to be assessed.

Methods. During an outbreak of measles, monovalent measles vaccine was administered as part of outbreak control to children aged 6 to 11 months. Active surveillance was used to detect cases of measles occurring during the following month. Children who did not develop measles were tested for measles antibody before their revaccination at 15 months of age.

Results. Of 81 children 6 to 11 months of age, 56 were vaccinated and two received immunoglobulins; the latter were excluded from the analysis. Measles occurred in 15 of the 79 children during and after the vaccination campaign, for an overall attack rate of 19%. The attack rate among unvaccinated children was 39% (9 of 23), compared with 11% (6 of 56) among those vaccinated (relative risk = 3.6, 95% confidence interval [CI] = 1.5 to 9.1). All of those who sustained measles in the vaccinated group developed the disease within 10 days after vaccination. The overall vaccine effectiveness was 73% (95% CI = 32% to 89%) when children were classified as vaccinated as soon as they were given measles vaccine. It rose to 96% (95% CI = 72% to 99%) when children were considered vaccinated 1 week postimmunization. Nineteen infants who were vaccinated and who did not develop measles during the outbreak were tested for measles antibody status at 15 months of age before revaccination. All had plaque reduction neutralizing antibody titers greater than 120.

Conclusion.This study confirms that measles vaccination of infants aged 6 to 11 months is an effective intervention measure during measles outbreaks.

Key Words: measles • measles vaccine • measles outbreak

Submitted on January 12, 1995
Accepted on April 10, 1995




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
S. S. Hutchins, A. Dezayas, K. L. Blond, J. Heath, W. Bellini, S. Audet, J. Beeler, W. Wattigney, and L. Markowitz
Evaluation of an Early Two-Dose Measles Vaccination Schedule
Am. J. Epidemiol., December 1, 2001; 154(11): 1064 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
C. Nicoara, K. Zach, D. Trachsel, D. Germann, and L. Matter
Decay of Passively Acquired Maternal Antibodies against Measles, Mumps, and Rubella Viruses
Clin. Vaccine Immunol., November 1, 1999; 6(6): 868 - 871.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
G. J. Fennelly and H. M. Adam
Measles Vaccine
Pediatr. Rev., May 1, 1998; 19(5): 178 - 179.
[Full Text] [PDF]